Trial Profile
A single center trial of liraglutide in patients with type 2 diabetes not controlled by oral hypoglycemic agents
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Oct 2016
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 15 Oct 2016 New trial record